We are monitoring the impact of COVID-19 & Recession alarm on MEA HPAPI Market Get in touch with us for detailed analysis Know More
Share on

Middle East and Africa High Potency API Market Research Report – Segmented By Type, Synthesis, Therapeutic Application & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis, Size, Share, Trends & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 2908
Pages: 145

MEA HPAPI Market Size (2022 to 2027)

The Middle East & Africa High Potency Active Pharmaceutical Ingredients Market size was valued at USD 1.31 billion in 2022. It is further estimated to be growing at a CAGR of 8.1% and worth USD 1.93 billion by 2027.

High Potency Active Pharmaceutical Ingredients (HPAPI) are pharmacological intermediates or substances active at concentrations below 150 micrograms per kilogram of body weight. They are characterized by a high degree of specificity and can bind to specific receptors or enzymes, which can cause cancer, reproductive problems, and developmental disorders at low doses. New drugs that are being released into the market have these high potency active pharmaceutical ingredients, leading to this market's high growth.

High Potency Active Pharmaceutical Ingredients have a new range of effective medicines to treat cancer and other hazardous diseases. After the human genome mapping was done, cancer drugs were made not only for different patients but also for different cancers. However, the production of these drugs is difficult since they are active at deficient concentrations. They can pose health problems to workers if they aren’t handled with care. Attentive monitoring has to be done to prevent contamination of drugs with foreign substances, requiring specialized equipment for managing air quality and handling HPAPI’s.

The driving factors of the Middle East and Africa's High Potency Active Pharmaceutical Ingredients market are their low price, rising healthcare prices, a growing number of pharmaceutical manufacturers and patients, and government initiatives to expand the usage of generic medicines to cut down healthcare costs.

This market's restraints are the high price of equipment, stringent regulatory requirements, and lack of skilled workers.

This research report on the Middle East and Africa HPAPI Market has been segmented and sub-segmented into the following categories:

By Type: 

  • Innovative HPAPI's
  • Generic HPAPI's

By Synthesis: 

  • Biotech HPAPI's
  • Synthetic HPAPI's

By Therapeutic Application: 

  • Oncology
  • Glaucoma
  • Hormonal Balance

By Country: 

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Geographically, the market is still in its emergent stages in the region. Factors such as increasing incidence of cancer, increasing research in cancer cures, and approvals for the production of new drugs will drive the market in this region.

Companies dominating the Middle East & Africa High Potency Active Pharmaceutical Ingredients Market profiled in the report are Pfizer, Inc. (U.S.), Novartis International AG (Switzerland), Sanofi (France), F. Hoffmann-La Roche Ltd. (Switzerland), Eli Lilly and Company (U.S.), Bristol-Myers Squibb (U.S.), Boehringer Ingelheim (Germany), Teva Pharmaceutical Industries Ltd. (Israel), Merck & Co., Inc. (U.S.), AbbVie Inc. (U.S.), and Mylan Inc. (U.S.).

1.Introduction    

   1.1 Market Definition   

   1.2 Study Deliverables  

   1.3 Base Currency, Base Year and Forecast Periods    

   1.4 General Study Assumptions 

2. Research Methodology 

   2.1 Introduction    

   2.2 Research Phases     

2.2.1 Secondary Research 

2.2.2 Primary Research

2.2.3 Econometric Modelling    

2.2.4 Expert Validation 

   2.3 Analysis Design  

   2.4 Study Timeline   

3. Overview  

   3.1 Executive Summary

   3.2 Key Inferences   

   3.3 Epidemology

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)     

   4.1 Market Drivers  

   4.2 Market Restraints   

   4.3 Key Challenges  

   4.4 Current Opportunities in the Market

5. Market Segmentation 

   5.1 Type

5.1.1 Innovative HPAPI's   

5.1.2 Generic HPAPI's   

5.1.3  Y-o-Y Growth Analysis, By Type    

5.1.4  Market Attractiveness Analysis, By Type    

5.1.5  Market Share Analysis, By Type    

   5.2 Synthesis    

5.2.1 Biotech HPAPI's   

   5.2.1.1 Biotech High- otency Active Pharmaceutical Ingredients Market, By Type

5.2.1.1.1 Innovative Biotech HPAPIs

5.2.1.1.2 Biosimilars    

5.2.2 Synthetic HPAPI's

   5.2.2.1 Synthetic High Potency Active Pharmaceutical Ingredients Market, By Type     

5.2.2.1.1 Innovative Synthetic HPAPIs   

5.2.2.1.2 Generic Synthetic HPAPIs  

5.2.3 Y-o-Y Growth Analysis, By Synthesis   

5.2.4 Market Attractiveness Analysis, By Synthesis   

5.2.5 Market Share Analysis, By Synthesis   

   5.3 Therapeutic Application 

5.3.1 Oncology    

5.3.2 Glaucoma   

5.3.3 Hormonal Balance   

5.3.4 Other therapeutic applications

5.3.5 Y-o-Y Growth Analysis, By Therapeutic Application 

5.3.6  Market Attractiveness Analysis, By Therapeutic Application    

5.3.7  Market Share Analysis, By Therapeutic Application

   5.4 Manufacturer    

5.4.1 Captive Manufacturers     

5.4.2 Merchant Manufacturers 

   5.4.2.1 Merchant HPAPI Manufacturers Market, By Type  

5.4.2.1.1 Innovative Merchant HPAPI Manufacturers

5.4.2.1.2 Generic Merchant HPAPI Manufacturers     

   5.4.2.2 Merchant HPAPI Manufacturers Market, By Type of Synthesis  

5.4.2.2.1 Synthetic HPAPIs  

5.4.2.2.2 Biotech HPAPIs     

5.4.3 Y-o-Y Growth Analysis, By Manufacturer    

5.4.4 Market Attractiveness Analysis, By Manufacturer   

5.4.5 Market Share Analysis, By Manufacturer    

6. Geographical Analysis 

   6.1 Introduction    

6.1.1 Regional Trends   

6.1.2 Impact Analysis    

6.1.3 Y-o-Y Growth Analysis 

   6.1.3.1 By Type 

   6.1.3.2 By Synthesis  

   6.1.3.3 By Therapeutic Application

   6.1.3.4 By Manufacturer

6.1.4  Market Attractiveness Analysis     

   6.1.4.1 By Type 

   6.1.4.2 By Synthesis  

   6.1.4.3 By Therapeutic Application

   6.1.4.4  By Manufacturer  

6.1.5  Market Share Analysis

   6.1.5.1 By Type 

   6.1.5.2 By Synthesis  

   6.1.5.3 By Therapeutic Application

   6.1.5.4 By Manufacturer

7.Strategic Analysis    

   7.1 PESTLE analysis 

7.1.1 Political  

7.1.2 Economic    

7.1.3 Social

7.1.4 Technological

7.1.5 Legal 

7.1.6 Environmental     

   7.2 Porter’s Five analysis   

7.2.1 Bargaining Power of Suppliers 

7.2.2 Bargaining Power of Consumers   

7.2.3 Threat of New Entrants    

7.2.4 Threat of Substitute Products and Service

  1. Middle East & Africa High Potency Active Pharmaceutical Ingredients Market, By Type, From 2022 - 2027 (USD Billion)
  2. Middle East & Africa Innovative HPAPI's  Market, By Region, From 2022 - 2027 (USD Billion)
  3. Middle East & Africa Generic HPAPI's Market, By Region, From 2022 - 2027 (USD Billion)
  4. Middle East & Africa High Potency Active Pharmaceutical Ingredients Market, By Synthesis, From 2022 - 2027 (USD Billion)
  5. Middle East & Africa Biotech HPAPI's Market, By Region, From 2022 - 2027 (USD Billion)
  6. Middle East & Africa Synthetic HPAPI's Market, By Region, From 2022 - 2027 (USD Billion)
  7. Middle East & Africa High Potency Active Pharmaceutical Ingredients Market, By Therapeutic Application, From 2022 - 2027 (USD Billion)
  8. Middle East & Africa Oncology Market, By Region, From 2022 - 2027 (USD Billion)
  9. Middle East & Africa Glaucoma Market, By Region, From 2022 - 2027 (USD Billion)
  10. Middle East & Africa Hormonal Balance Market, By Region, From 2022 - 2027 (USD Billion)
  11. Middle East & Africa other therapeutic applications Market, By Region, From 2022 - 2027 (USD Billion)
  12. Middle East High Potency Active Pharmaceutical Ingredients Market, By Type, From 2022 - 2027 (USD Billion)
  13. Middle East High Potency Active Pharmaceutical Ingredients Market, By Synthesis, From 2022 - 2027 (USD Billion)
  14. Middle East High Potency Active Pharmaceutical Ingredients Market, By Therapeutic Application, From 2022 - 2027 (USD Billion)
  15. Africa High Potency Active Pharmaceutical Ingredients Market, By Type, From 2022 - 2027 (USD Billion)
  16. Africa High Potency Active Pharmaceutical Ingredients Market, By Synthesis, From 2022 - 2027 (USD Billion)
  17. Africa High Potency Active Pharmaceutical Ingredients Market, By Therapeutic Application, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample